3.Migraine-like Headache with Focal Neurologic Deficit and CSF Pleocytosis.
Dong Wook KIM ; Yong Seok LEE ; Kon CHU ; Hyunwoo NAM ; Seong Ho PARK
Journal of the Korean Neurological Association 2001;19(3):302-304
Distinct from migraine with aura or hemiplegic migraine, a rare clinical entity of migraine-like headache, transient focal neurologic deficit and CSF pleocytosis (HaNDL) has been known. Although the etiology or pathogenesis is unknown, possibility of viral infection or inflammation has been suggested. We report a 25-year-old man diagnosed as HaNDL with literature review. (J Korean Neurol Assoc 19(3):302~304, 2001)
Adult
;
Aphasia
;
Headache*
;
Humans
;
Inflammation
;
Leukocytosis*
;
Migraine Disorders
;
Migraine with Aura
;
Neurologic Manifestations*
4.Lupus Pneumonitis.
Sihoon LEE ; Jae Hyun CHANG ; Jung Min KIM ; Jeok Geum CHU ; Yong Beom PARK ; Soo Kon LEE
Korean Journal of Medicine 2001;60(4):404-405
No abstract available.
Pneumonia*
5.A Psychiatric Side Effect of Levetiracetam Can Mimic a Relapse of Anti-Leucine-Rich Glioma Inactivated 1 Encephalitis.
Yoonhyuk JANG ; Soon Tae LEE ; Kon CHU ; Sang Kun LEE
Journal of Clinical Neurology 2018;14(3):413-414
No abstract available.
Encephalitis*
;
Glioma*
;
Recurrence*
6.The Role of Video-EEG Monitoring: Purpose and outcome.
Sang Kun LEE ; Kyoung Il PARK ; Yun Sook JHANG ; Hyun Kyung KIM ; Kon CHU ; Chun Kee CHUNG
Journal of Korean Epilepsy Society 2008;12(2):78-84
BACKGROUND AND PURPOSE: We performed this study to explore the various diagnostic roles of video-EEG monitoring (VEM) and to assess the outcome after VEM. METHODS: 1749 patients who underwent VEM in the adult epilepsy section were included. We classified purposes of VEM and assessed outcome after VEM or epilepsy surgery guided by VEM. The outcome was assessed according to seizure frequency during the previous 12 months from the day of follow-up evaluation. RESULTS: The purposes of VEM were presurgical evaluation (68.5%), confirmation of epilepsy (15%), classification of seizures (9.4%), diagnosis of pseudoseizures (5.5%), and detection of nonconvulsive status epilepticus (1.7%). The efficiency of VEM was 89.2%, highest for presurgical evaluation (97.1%) and lowest for confirmation of seizures (66.0%). The number of events detected and the number of days needed differed according to the purposes of VEM. Epilepsy surgery was performed in 629 patients. The outcome of patients with epilepsy surgery was significantly better compared with patients without surgery despite presurgical evaluation (p<0.0001). Various other illnesses with transient symptoms as well as various epileptic syndromes were diagnosed by VEM. Better outcomes were observed in patients in whom VEM was used for classification and confirmation of seizures compared with patients in whom VEM was used for presurgical evaluation. CONCLUSIONS: VEM is a useful tool for various purposes. The efficiency, number of events and days of VEM differed according to the purposes. Patient outcome was also dependent on the purpose of the VEM as well as on treatment modalities.
Adult
;
Epilepsy
;
Follow-Up Studies
;
Humans
;
Seizures
;
Status Epilepticus
7.Human Neural Stem Cells Transplantation in Experimental Intracerebral Hemorrhage.
Sang Wuk JEONG ; Kon CHU ; Keun Hwa JUNG ; Seung U KIM ; Man Ho KIM ; Jae Kyu ROH
Journal of the Korean Neurological Association 2003;21(2):183-190
BACKGROUND: Intracerebral hemorrhage (ICH) is associated with a considerable proportion of stroke and head injuries, but except for supportive care, there is no medical therapy available. Transplantation of human neural stem cells (NSCs) can be used to reduce behavioral deficit in experimental ischemic infarct model. However, effect of stem cell transplantation in experimental intracerebral hemorrhage (ICH) is unknown. We hypothesized that NSCs could migrate and differentiate into neurons or glial cells, and improve functional outcome in ICH. METHODS: Experimental ICH was made by intrastriatal administration of bacterial collagenase in adult rats. Animals were randomized to receive intravenously either immortalized Lac-Z positive human NSCs (5x1 06 in 500microL, n=15) or same volume of saline (n=12) on the following day. Animals were evaluated for 8 weeks after surgery with behavioral test battery. After 8 weeks, animals were sacrificed and the brains were sectioned. Transplanted NSCs were detected by X-gal histochemistry or beta-gal immunohistochemistry, and differentiation of grafted NSCs were evaluated by double labeling of GFAP, NeuN, or neurofilament. RESULTS: Transplanted NSCs migrated to the side of peri-hematomal areas, and differentiated into neurons and astrocytes. NSCs injection group showed improved performances on rotarod test after 2 weeks and on limb placing test after 5 weeks compared with control group (p<0.05) and these effect persisted up to 8 weeks. CONCLUSIONS: Intravenously injected NSCs enter rat brain with ICH, and differentiate into astrocytes or neuronal cell, which lead to functional recovery. These findings show the possibility that NSCs can be used to reduce neurological deficits in the experimental ICH.
Adult
;
Animals
;
Astrocytes
;
Brain
;
Cerebral Hemorrhage*
;
Collagenases
;
Craniocerebral Trauma
;
Extremities
;
Humans*
;
Immunohistochemistry
;
Neural Stem Cells*
;
Neuroglia
;
Neurons
;
Rats
;
Rotarod Performance Test
;
Stem Cell Transplantation
;
Stroke
;
Transplants
8.Rituximab Treatment for Idiopathic Hypertrophic Pachymeningitis.
Yoonhyuk JANG ; Soon Tae LEE ; Keun Hwa JUNG ; Kon CHU ; Sang Kun LEE
Journal of Clinical Neurology 2017;13(2):155-161
BACKGROUND AND PURPOSE: Hypertrophic pachymeningitis (HP) is a rare disease caused by autoimmunity in the meninx that causes various neurologic symptoms, including headache, seizures, weakness, paresthesia, and cranial nerve palsies. Although the first-line therapy for HP is steroids, many HP cases are refractory to steroids or recur when the steroids are tapered. Here we report three HP cases that were successfully treated with rituximab (RTX). METHODS: From an institutional cohort recruited from April 2012 to July 2016, three HP cases that were identified to be steroid-refractory were treated with RTX (four weekly doses of 375 mg/m²). Clinical improvement was assessed by the number of relapses of any neurologic symptom and the largest dural thickness in MRI. RESULTS: All three patients were recurrence-free of neurologic symptoms and exhibited prominent decreases in the dural thickness after RTX treatment. No adverse events were observed in the patients. CONCLUSIONS: We suggest RTX as a second-line therapy for steroid-refractory HP. Further studies are warranted to confirm this observation in a larger population and to consider RTX as a first-line therapy.
Autoimmunity
;
Cohort Studies
;
Cranial Nerve Diseases
;
Headache
;
Humans
;
Magnetic Resonance Imaging
;
Meningitis*
;
Neurologic Manifestations
;
Paresthesia
;
Rare Diseases
;
Recurrence
;
Rituximab*
;
Seizures
;
Steroids
9.Cluster-like Headache Secondary to Cerebral Venous Thrombosis.
Kyung Il PARK ; Kon CHU ; Jong Moo PARK ; Manho KIM
Journal of Clinical Neurology 2006;2(1):70-73
Cluster headache (CH) is considered a primary headache syndrome. However, symptomatic cases that resemble CH have also been reported. A patient with cerebral venous thrombosis presented with ipsilateral frontal pain accompanied by ophthalmoparesis, nasal congestion, and lacrimation. The patient's headache showed a dramatic response to oxygen. He experienced no further cluster-like headaches after treatment with an anticoagulant. This case suggests the possible role of venous stasis of the cavernous sinus in cluster-like headache.
Cavernous Sinus
;
Cluster Headache
;
Estrogens, Conjugated (USP)
;
Headache Disorders
;
Headache*
;
Humans
;
Ophthalmoplegia
;
Oxygen
;
Venous Thrombosis*
10.A Case of Malignant Meningioma with Multiple Extracranial Metastasis.
Min Woo PAIK ; Kon HUH ; Seung Jae LEE ; Hyo Il PARK ; Jong Eun CHU
Journal of Korean Neurosurgical Society 1979;8(1):87-94
Meningioma is generally regarded as benign and extracranial metastasis of intracranial meningioma is rare. About 60 cases of distant metastasis of meningioma have now been reported. Angioblastic meningioma, although a rare type, shows rapid growth and sarcomatous change frequently, and has higher incidence of metastasis than other types of meningioma. The authors report a case of malignant angioblastic meningioma arisen in left olfactory groove with multiple metastasis to skeletal system. The available literature regarding these tumors is reviewed.
Incidence
;
Meningioma*
;
Neoplasm Metastasis*